Literature DB >> 15181242

Apolipoprotein E knockout mice as a model of behavioral dysfunction.

Illana Gozes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15181242     DOI： 10.1385/JMN:23:3:149

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN： 0895-8696            Impact factor:   3.444


× No keyword cloud information.
  11 in total

1.  Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease.

Authors:  I Gozes; M Bachar; A Bardea; A Davidson; S Rubinraut; M Fridkin; E Giladi
Journal:  J Neurobiol       Date:  1997-09

Review 2.  A new concept in the pharmacology of neuroprotection.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

3.  M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice.

Authors:  A Fisher; R Brandeis; S Chapman; Z Pittel; D M Michaelson
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

4.  Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

Authors:  I Gozes; O Perl; E Giladi; A Davidson; O Ashur-Fabian; S Rubinraut; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience.

Authors:  J Grootendorst; E R de Kloet; S Dalm; M S Oitzl
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.

Authors:  Y Chen; L Lomnitski; D M Michaelson; E Shohami
Journal:  Neuroscience       Date:  1997-10       Impact factor: 3.590

7.  Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment.

Authors:  I Genis; A Fisher; D M Michaelson
Journal:  J Neurochem       Date:  1999-01       Impact factor: 5.372

8.  Protective peptides that are orally active and mechanistically nonchiral.

Authors:  Douglas E Brenneman; Catherine Y Spong; Janet M Hauser; Daniel Abebe; Albert Pinhasov; Tania Golian; Illana Gozes
Journal:  J Pharmacol Exp Ther       Date:  2004-03-08       Impact factor: 4.030

9.  Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

Authors:  I Gordon; E Grauer; I Genis; E Sehayek; D M Michaelson
Journal:  Neurosci Lett       Date:  1995-10-13       Impact factor: 3.046

Review 10.  From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.

Authors:  Illana Gozes; Inna Divinsky; Inbar Pilzer; Mati Fridkin; Douglas E Brenneman; Avron D Spier
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866
View more
  2 in total

1.  The Future for Dementia Research: a Perspective from the Journal of Molecular Neuroscience.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-11       Impact factor: 3.444

2.  Lifelong vitamin E intake retards age-associated decline of spatial learning ability in apoE-deficient mice.

Authors:  Shelley R McDonald; Michael J Forster
Journal:  Age (Dordr)       Date:  2005-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.